These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31187224)

  • 1. Inhibitory activity of chitosan nanoparticles against Cryptosporidium parvum oocysts.
    Ahmed SA; El-Mahallawy HS; Karanis P
    Parasitol Res; 2019 Jul; 118(7):2053-2063. PubMed ID: 31187224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
    Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
    Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The suppressive effect of Mekabu fucoidan on an attachment of Cryptosporidium parvum oocysts to the intestinal epithelial cells in neonatal mice.
    Maruyama H; Tanaka M; Hashimoto M; Inoue M; Sasahara T
    Life Sci; 2007 Jan; 80(8):775-81. PubMed ID: 17157323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of particulate drug formulation against C. parvum: Formulation, characterization and in vivo efficacy.
    Blanco-García E; Guerrero-Callejas F; Blanco-Méndez J; Gómez-Couso H; Luzardo-Álvarez A
    Eur J Pharm Sci; 2016 Sep; 92():74-85. PubMed ID: 27381880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of two commercial disinfectants on the viability and infectivity of Cryptosporidium parvum oocysts.
    Castro-Hermida JA; Pors I; Méndez-Hermida F; Ares-Mazás E; Chartier C
    Vet J; 2006 Mar; 171(2):340-5. PubMed ID: 16490718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of amine-based disinfectant KENO™COX on the infectivity of Cryptosporidium parvum oocysts.
    Naciri M; Mancassola R; Fort G; Danneels B; Verhaeghe J
    Vet Parasitol; 2011 Jun; 179(1-3):43-9. PubMed ID: 21354705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silver Nanoparticles Decrease the Viability of Cryptosporidium parvum Oocysts.
    Cameron P; Gaiser BK; Bhandari B; Bartley PM; Katzer F; Bridle H
    Appl Environ Microbiol; 2016 Jan; 82(2):431-7. PubMed ID: 26497464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvum.
    Huang W; Choi R; Hulverson MA; Zhang Z; McCloskey MC; Schaefer DA; Whitman GR; Barrett LK; Vidadala RSR; Riggs MW; Maly DJ; Van Voorhis WC; Ojo KK; Fan E
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533246
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel lactate dehydrogenase inhibitors with in vivo efficacy against Cryptosporidium parvum.
    Li K; Nader SM; Zhang X; Ray BC; Kim CY; Das A; Witola WH
    PLoS Pathog; 2019 Jul; 15(7):e1007953. PubMed ID: 31356619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Throughput Screening of Drugs Against the Growth of Cryptosporidium parvum In Vitro by qRT-PCR.
    Zhang H; Zhu G
    Methods Mol Biol; 2020; 2052():319-334. PubMed ID: 31452170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-protozoal activity of extracts from chicory (Cichorium intybus) against Cryptosporidium parvum in cell culture.
    Woolsey ID; Valente AH; Williams AR; Thamsborg SM; Simonsen HT; Enemark HL
    Sci Rep; 2019 Dec; 9(1):20414. PubMed ID: 31892721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feeding activated charcoal from bark containing wood vinegar liquid (nekka-rich) is effective as treatment for cryptosporidiosis in calves.
    Watarai S; Tana ; Koiwa M
    J Dairy Sci; 2008 Apr; 91(4):1458-63. PubMed ID: 18349239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of curcumin and paromomycin against Cryptosporidium parvum infection in a BALB/c model.
    Asadpour M; Namazi F; Razavi SM; Nazifi S
    Vet Parasitol; 2018 Jan; 250():7-14. PubMed ID: 29329627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiprotozoal activity of silver nanoparticles against Cryptosporidium parvum oocysts: New insights on their feasibility as a water disinfectant.
    Hassan D; Farghali M; Eldeek H; Gaber M; Elossily N; Ismail T
    J Microbiol Methods; 2019 Oct; 165():105698. PubMed ID: 31446036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptosporidium parvum bovine genotype oocysts in the respiratory samples of an AIDS patient: efficacy of treatment with a combination of azithromycin and paromomycin.
    Meamar AR; Rezaian M; Rezaie S; Mohraz M; Kia EB; Houpt ER; Solaymani-Mohammadi S
    Parasitol Res; 2006 May; 98(6):593-5. PubMed ID: 16416289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of viability assays for Cryptosporidium parvum oocysts after disinfection.
    Joachim A; Eckert E; Petry F; Bialek R; Daugschies A
    Vet Parasitol; 2003 Jan; 111(1):47-57. PubMed ID: 12523978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short communication: effect of pomegranate-residue supplement on Cryptosporidium parvum oocyst shedding in neonatal calves.
    Weyl-Feinstein S; Markovics A; Eitam H; Orlov A; Yishay M; Agmon R; Miron J; Izhaki I; Shabtay A
    J Dairy Sci; 2014 Sep; 97(9):5800-5. PubMed ID: 24952772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum.
    Klein P; Cirioni O; Giacometti A; Scalise G
    J Antimicrob Chemother; 2008 Nov; 62(5):1101-4. PubMed ID: 18653486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Content Screening for Cryptosporidium Drug Discovery.
    Love MS; McNamara CW
    Methods Mol Biol; 2020; 2052():303-317. PubMed ID: 31452169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.